Cancer medicine · 2025
Terahertz Photonic Crystal Fiber Sensor for Cancer Cell Detection: Performance Analysis and Discrimination.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khandakar Kayab, Faruk Md Omar, Ferdous A H M Iftekharul, Naim Md Naimur Rahman
Аннотация
BACKGROUND: Cancer cells exhibit significant heterogeneity, making their detection a challenging task.
METHODS: In this study, a unique Photonic Crystal Fiber (PCF) sensor with a circular core design and curved trapezoidal cladding is presented. It is especially designed to detect cancer cells efficiently.
RESULTS: The proposed sensor demonstrates exceptional performance, achieving a maximum relative sensitivity (RS) of 99.71% for breast cancer type II cells, along with similarly high sensitivities for cervical, adrenal gland, skin, blood, and breast cancer type I cells. Key performance parameters highlight its accuracy in detecting cancer cells via minute changes in refractive index (RI), including ultra-low confinement loss (CL) of up to 6.69 × 10-13 dB/cm and effective material loss (EML) as low as 0.00161 cm-1.
CONCLUSIONS: The sensor's high accuracy, rapid response time, and ability to selectively target tumor cells make it a breakthrough in early cancer detection. Moreover, its compact size and potential for easy fabrication enhance its applicability in emergency settings. This cutting-edge approach represents a major advancement in medical technology, paving the way for more efficient and targeted cancer diagnostics.
METHODS: In this study, a unique Photonic Crystal Fiber (PCF) sensor with a circular core design and curved trapezoidal cladding is presented. It is especially designed to detect cancer cells efficiently.
RESULTS: The proposed sensor demonstrates exceptional performance, achieving a maximum relative sensitivity (RS) of 99.71% for breast cancer type II cells, along with similarly high sensitivities for cervical, adrenal gland, skin, blood, and breast cancer type I cells. Key performance parameters highlight its accuracy in detecting cancer cells via minute changes in refractive index (RI), including ultra-low confinement loss (CL) of up to 6.69 × 10-13 dB/cm and effective material loss (EML) as low as 0.00161 cm-1.
CONCLUSIONS: The sensor's high accuracy, rapid response time, and ability to selectively target tumor cells make it a breakthrough in early cancer detection. Moreover, its compact size and potential for easy fabrication enhance its applicability in emergency settings. This cutting-edge approach represents a major advancement in medical technology, paving the way for more efficient and targeted cancer diagnostics.